Skip to main content

EDITORIAL article

Front. Cell Dev. Biol., 05 January 2023
Sec. Molecular and Cellular Pathology
Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1095235

Editorial: Regional and molecular fingerprint of adipogenesis in aging and disease

  • 1Group for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia
  • 2Department of Physiology and Cellular Biophysics, Columbia University, New York, NY, United States
  • 3Laboratory of Regenerative Hematopoiesis, Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) and Department of Biomedical Sciences, University of Lausanne (UNIL), Lausanne, Switzerland

During aging, adipose tissue (AT) undergoes dramatic changes, leading to white AT (WAT) and brown AT (BAT) dysfunction and redistribution, changes in the number and differentiation of adipocyte progenitors and accumulation of inflammatory and senescent cells. Since AT plays an integral role in healthspan, understanding of molecular changes in the AT microenvironment during aging and disease would contribute to fundamental and translational research of AT. This Research Topic has collected five original research and 3 review papers on the AT in aging and pathologies.

Population diversity of AT cells has been recently determined at single cell level (Emont et al., 2022). The pool of AT progenitor/stromal cells (ASCs) within the stromal vascular fraction are source of adipocytes and are crucial for the maintenance of AT different location (subcutaneous, visceral, bone marrow) with distinct functions (WAT and BAT). Profiles of AT progenitors vary according to anatomical and functional apportionment and arrange region-specific AT microenvironments. Therefore, diverse ASCs are included in maintenance of subcutaneous, visceral AT or bone marrow adipose tissue (BMAT), and their cellular and molecular dissection is of paramount interests for understanding of aging-related AT alteration.

Aging is gradual process of changes and age-related AT alternations include reduction in the ASC number and their adipogenic ability. Da Nadyellem Silva and Amato review the origin, the features, and the age-related changes of thermogenic AT. Thermogenic BAT declines with aging due to reduced ASC number, differentiation, mitochondrial function, and altered paracrine and endocrine signals. Although promoting the browning of WAT can be a promising anti-obesity and anti-cancer strategy, molecular targets still need to be identified (Cheng et al., 2019; Wolfrum and Gerhart-Hines, 2022). Aging is not the only process that contributes to the changes in AT. Thus, hypoxia-inducible factor (Hif)-3α expression and methylation are AT depot-specific and related to AT dysfunction in states of inflammation and obesity (Pfeiffer et al., 2016). Moreover, Cuomo et al. proved that Hif3α regulates metabolic reprogramming and BAT induction since Hif3α silencing promotes “browning” of white precursor cells. These findings suggest that modification at transcriptional level can bring certain beneficial effects in preserving BAT functions.

In the bone marrow microenvironment, aging is followed by the expansion of BMAT and often associated with bone diseases, such as osteoporosis. The origin of BMAT is not fully elucidated but it is possible that expansion of BMAT occurs due to uncontrolled differentiation of mesenchymal stromal cells (MSCs). The study by Zhang et al. shows that SUMO specific peptidase (SENP)3 knockdown recovers osteogenic differentiation and impairs undesirable adipogenesis in MSCs of glucocorticoid-induced osteoporosis (GIOP) mice. Thus, SENP3 might be realistic MSC target in GIOP disease and might help to combat BMAT expansion and aged osteoporotic profile prevention. Precise elimination of senescent AT cells by using senolytics, senomorphics or exercise can overcome AT aging, improving insulin sensitivity and extending lifespan. Therefore, we can conclude that there exists certain overlap in the action of anti-aging and the anti-adiposopathy agents.

AT dysfunction (adiposopathy) and obesity are main risk factors for age-related states including diabetes, cancer, and cardiovascular diseases. Together with aging, AT inflammatory microenvironment (metaflammation) is consider as a major denominator of AT-related pathologies. Thus, it is of fundamental importance to elucidate whether inflammaging and metaflammation share common inflammatory pathways. Inflammation in obese AT is marked by multiple inflammatory cytokine production, as well as infiltration of AT monocytes, macrophages (ATMs) Choi et al. and leukocytes, leading to chronic inflammation, dysregulated metabolism and AT remodelling (Kahn et al., 2019). Specific deletion of Connexin 43 (Cx43) in ATMs indicates a protection from diet-induced inflammation Choi et al. Thus, it is speculated that this can be used as therapeutic approach to reduce obesity-associated inflammation. In addition to ATMs, presence of regulatory T cells (Tregs) is implicated in age-related insulin resistance (Bapat et al., 2015). However, inflammation governs adipogenesis. As reported by Cuomo et al., inflammation leads to Hif3α upregulation and finally, dysregulated adipogenesis program. On the other hand, expression of inflammatory markers, such as a major innate immune protein lysozyme (Lyz2) gene sustains adipogenesis Lluch et al. as shown in cell line culture.

As expected, due to specific functions and metabolism, different AT depots respond in distinct ways to inflammatory stimuli. Visceral adipocytes have a lower gene expression of adipogenic markers and a higher expression of immunogenic markers in comparison with subcutaneous adipocytes, where ASCs from both depots of obese women retained their region-specific adipogenic capacity during obesity Mathur et al. Moreover, accumulation of visceral and loosing of subcutaneous AT is a hallmark of aging in humans, where central obesity and increased VAT accumulation are recognized as valuable anatomic diagnostic criterion for metabolic diseases (Bays et al., 2014). Interestingly, aging-associated loss of subcutaneous AT can be regulated by population of aging regulatory cells (ARCs) that inhibit proliferation and differentiation of ASCs (Nguyen et al., 2021) and it will be important to reveal their role in different AT depots. Homeotic genes (Hox) are evolutionary conserved regulators that serve as cellular positional identity markers and are involved in regional distribution and specification of AT. However, the significance of Hox genes in aged and diseased AT properties is yet to investigate. Despite the cell-centric concept of region-specific AT differences, contemporary approaches favour global and systemic assessment of AT functions particularly in pathological states (Bays et al., 2014). Thus, combined and integrated single-cell and multi-regional investigations of AT are required.

Therefore, regulation of ATM, Treg, ARC populations, and inflammatory cues can contribute to conceiving of new treatments for AT disorders, where both global and region-specific AT changes have to be considered.

Author contributions

Conceptualization: DT. Writing and editing: all authors. Final approval: all authors.

Acknowledgments

Guest Editor Team likes to thank all the Authors and Reviewers who contributed with their work to this Research Topic. Guest Editors are thankful to the Frontiers in Cell and Developmental Biology for support throughout the editorial process.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Bapat, S. P., Myoung Suh, J., Fang, S., Liu, S., Zhang, Y., Cheng, A., et al. (2015). Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528 (7580), 137–141. doi:10.1038/nature16151

PubMed Abstract | CrossRef Full Text | Google Scholar

Bays, H. (2014). Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr. Opin. Endocrinol. Diabetes Obes. 21 (5), 345–351. doi:10.1097/MED.0000000000000093

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng, C. F., Ku, H. C., Cheng, J. J., Chao, S. W., Li, H. F., Lai, P. F., et al. (2019). Adipocyte browning and resistance to obesity in mice is induced by expression of ATF3. Commun. Biol. 2, 389. doi:10.1038/s42003-019-0624-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Emont, M. P., Jacobs, C., Essene, A. L., Pant, D., Tenen, D., Colleluori, G., et al. (2022). A single-cell atlas of human and mouse white adipose tissue. Nature 603 (7903), 926–933. doi:10.1038/s41586-022-04518-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Kahn, C. R., Wang, G., and Lee, K. Y. (2019). Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. J. Clin. investigation 129 (10), 3990–4000. doi:10.1172/JCI129187

PubMed Abstract | CrossRef Full Text | Google Scholar

Nguyen, H. P., Lin, F., Yi, D., Xie, Y., Dinh, J., Xue, P., et al. (2021). Aging-dependent regulatory cells emerge in subcutaneous fat to inhibit adipogenesis. Dev. Cell 56 (10), 1437–1451.e3. e3. doi:10.1016/j.devcel.2021.03.026

PubMed Abstract | CrossRef Full Text | Google Scholar

Pfeiffer, S., Krüger, J., Maierhofer, A., Böttcher, Y., Klöting, N., El Hajj, N., et al. (2016). Hypoxia-inducible factor 3A gene expression and methylation in adipose tissue is related to adipose tissue dysfunction. Sci. Rep. 6, 27969. doi:10.1038/srep27969

PubMed Abstract | CrossRef Full Text | Google Scholar

Wolfrum, C., and Gerhart-Hines, Z. (2022). Fueling the fire of adipose thermogenesis. Sci. (New York, N.Y.) 375 (6586), 1229–1231. doi:10.1126/science.abl7108

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: adipose tissue, stem cells, metabolism, inflammation, aging, obesity, cancer, mitochondria

Citation: Trivanović D, Labella R, Tratwal J and Bugarski D (2023) Editorial: Regional and molecular fingerprint of adipogenesis in aging and disease. Front. Cell Dev. Biol. 10:1095235. doi: 10.3389/fcell.2022.1095235

Received: 10 November 2022; Accepted: 20 December 2022;
Published: 05 January 2023.

Edited and reviewed by:

Ramani Ramchandran, Medical College of Wisconsin, United States

Copyright © 2023 Trivanović, Labella, Tratwal and Bugarski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Drenka Trivanović, drenka.trivanovic@imi.bg.ac.rs

Download